Abrdn World Healthcare Fund (NYSE:THW) Shares Down 1.9% – Here’s Why

Shares of Abrdn World Healthcare Fund (NYSE:THW) were down 1.9% during trading on Thursday . The company traded as low as $12.27 and last traded at $12.2750. Approximately 115,241 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 211,506 shares. The stock had previously closed at $12.51.

Abrdn World Healthcare Fund Trading Up 1.7%

The firm’s 50-day moving average is $12.73 and its 200-day moving average is $12.29.

Abrdn World Healthcare Fund Dividend Announcement

The company also recently announced a monthly dividend, which was paid on Friday, January 30th. Investors of record on Friday, January 23rd were paid a dividend of $0.1167 per share. The ex-dividend date was Friday, January 23rd. This represents a c) dividend on an annualized basis and a dividend yield of 11.2%.

Institutional Trading of Abrdn World Healthcare Fund

Several hedge funds have recently bought and sold shares of THW. Newbridge Financial Services Group Inc. bought a new position in shares of Abrdn World Healthcare Fund during the 2nd quarter valued at approximately $31,000. Advisory Services Network LLC purchased a new stake in shares of Abrdn World Healthcare Fund in the third quarter valued at approximately $43,000. Ameriflex Group Inc. purchased a new position in shares of Abrdn World Healthcare Fund during the third quarter valued at $79,000. B. Riley Wealth Advisors Inc. purchased a new position in Abrdn World Healthcare Fund during the 2nd quarter valued at about $113,000. Finally, HighTower Advisors LLC purchased a new position in Abrdn World Healthcare Fund during the fourth quarter valued at approximately $168,000.

About Abrdn World Healthcare Fund

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.